A new trading day began on Tuesday, with AbCellera Biologics Inc (NASDAQ: ABCL) stock price up 3.31% from the previous day of trading, before settling
On Tuesday, AbCellera Biologics Inc (NASDAQ: ABCL) was -8.14% drop from the session before settling in for the closing price of $4.67. A 52-week range
AbCellera Biologics Inc (NASDAQ: ABCL) established initial surge of 7.26% at $4.58, as the Stock market unbolted on Wednesday, before settling in for the price
A new trading day began on Friday, with AbCellera Biologics Inc (NASDAQ: ABCL) stock price up 0.24% from the previous day of trading, before settling
AbCellera Biologics Inc (NASDAQ: ABCL) on Tuesday, soared 0.46% from the previous trading day, before settling in for the closing price of $4.34. Within the
AbCellera Biologics Inc (NASDAQ: ABCL) started the day on Thursday, with a price decrease of -2.19% at $4.47, before settling in for the price of
AbCellera Biologics Inc (NASDAQ: ABCL) on Monday, plunged -3.72% from the previous trading day, before settling in for the closing price of $5.11. Within the
AbCellera Biologics Inc (NASDAQ: ABCL) started the day on Thursday, with a price increase of 0.60% at $5.02, before settling in for the price of
A new trading day began on Monday, with AbCellera Biologics Inc (NASDAQ: ABCL) stock price up 14.96% from the previous day of trading, before settling
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.